MARKET SUMMERY
DPT stands for diphtheria,
pertussis (whooping cough), and tetanus. Market Research Future (MRFR) has
published and released a research report about the global DPT vaccine market
size that anticipates growth for this market at
7.3% CAGR (Compound Average Growth Rate) between 2022 and 2030. In terms of
market value, the worth of global DPT vaccine
market has been estimated to be the USD 8342.3 million by the end of the forecast
period.
The major factors facilitating
the growth of the global DPT vaccine market are increasing deaths in children
due to pertussis and increasing awareness about DPT vaccines. The global DPT vaccine market insights has been segmented into application, type, and lastly,
region. The application-based segmentation segments
this market into diphtheria, pertussis, and tetanus. By type, this market has
been segmented into DPaT, DTwP, and Tdap.
Analyzing the market
structure, this report offers insights about factors affecting the market
growth. Estimating the market size and forecasting the revenue, this reports
covers and observes the competitive developments of market players that include
mergers and acquisitions, joint ventures, new product developments, research
and developments (R&D), and strategic alliances.
KEY PLAYERS
The global DPT vaccine market players include
ü
Chiron
Pharmaceutical Pvt Ltd (India),
ü GSK (USA),
ü Lanzhou
Institute of Biological Products (China),
ü Merck
& Co., Inc (USA),
ü Sanofi
(France), and
ü Wyeth
(USA).
DTP MARKET REGIONAL ANALYSIS
The regional segmentation
of the global DPT vaccine market segments the global market into regional
markets namely North America, Asia Pacific, Europe, and the Middle East &
Africa (MEA). North America is the largest regional market where steady market
growth is expected during the forecast period. In this region, the market is
growing due to the presence of many important market players in North America,
especially in the USA. Other important reasons for market growth in this region
are the availability of most advanced medical facilities in this region,
emphasis on vaccination against DPT, established
healthcare sector, and advanced R&D going on
in the medical sector. After the USA, Canada and Mexico are the most important
country-specific markets in this region.
Europe is the second
largest regional market. The factors encouraging the market growth in this
region are a high density of population, established
healthcare sector, high level of technological advancement that is second only
to North America, and presence of many key market players. The main country-specific markets in this region are
the strongest economies known as France, Germany, and the UK, followed
by the remaining countries of Europe.
The Asia
Pacific is another significant market as healthcare sector is developing in
countries like China and India. Advanced medical facilities and rapid
technological advancement are available in Japan. The rural market in countries
like China and India is still untapped which due to the high density of population can be a lucrative
market once tapped into. Aided by the local government and the World Health Organization (WHO), many
vaccination programs are being organized in the rural areas of countries like
India. During the forecast period, the Asia
Pacific region is likely to grow positively.
The MEA region has the least market share
due to poor countries, lack of awareness, lack of education, low standard of medical
facilities, lack of healthcare facilities, and majority governments not
considering healthcare a priority.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
